TEM images of the reconstituted liposomes ( EDS mapping (Figure S1(A)) showed that uranyl acetate was more abundant in the aqueous solution than in the liposomes
For this group, an oral option that delivers 70% to 80% of the glycemic benefit of an injection is better than no GLP-1 therapy at all
Energy levels stabilize at higher baselines

Contact your healthcare provider if you experience: Severe or persistent abdominal pain that does not improve with standard measures or worsens over time Persistent vomiting that prevents adequate fluid or food intake, increasing the risk of dehydration Signs of dehydration , including decreased urination, dark urine, dizziness, dry mouth, or extreme thirst Inability to tolerate oral intake for more than 24 hours Symptoms suggestive of pancreatitis , such as severe upper abdominal pain radiating to the back, often accompanied by nausea and vomiting New or worsening heartburn that does not respond to over-the-counter antacids Weight loss that exceeds expected therapeutic effects or occurs rapidly with other concerning symptoms Blood in vomit or stool , which may appear as black, tarry stools or coffee-ground emesis Right upper quadrant pain, fever, or yellowing of skin/eyes , which may indicate gallbladder disease (more common during weight loss) Severe abdominal distension or inability to pass gas or stool , which could suggest bowel obstruction Markedly reduced urine output , which may indicate acute kidney injury from dehydration Tirzepatide carries a boxed warning regarding the risk of thyroid C-cell tumors observed in animal studies, and while gastrointestinal symptoms are not directly related to this risk, any new or concerning symptoms should be evaluated

Diabetic patients frequently must take multiple medications to manage their condition and should monitor potential interactions
All of this helps us create a customized plan to aid in your weight loss journey